BRIMONIDINE TARTRATE

BRIMONIDINE TARTRATE was reported 17166 times

BRIMONIDINE TARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONJUNCTIVAL FOLLICLES 11 0.3438
1 HYPOTONY MACULOPATHY 12 0.2927
2 INFECTIOUS CRYSTALLINE KERATOPATHY 8 0.2162
3 KERATITIS INTERSTITIAL 9 0.1765
4 OCULAR SURFACE DISEASE 45 0.1601
5 TRABECULECTOMY 9 0.0978
6 INTRAOCULAR PRESSURE FLUCTUATION 17 0.0863
7 CORNEAL NEOVASCULARISATION 21 0.0850
8 CONJUNCTIVAL SCAR 12 0.0795
9 CORNEAL OPACITY 107 0.0783
10 HYPOTONY OF EYE 28 0.0667
11 OPEN ANGLE GLAUCOMA 39 0.0635
12 ANTERIOR CHAMBER FIBRIN 8 0.0620
13 CHOROIDAL DETACHMENT 34 0.0613
14 CORNEAL INFILTRATES 18 0.0573
15 PALPABLE PURPURA 15 0.0547
16 PRODUCT DROPPER ISSUE 42 0.0534
17 SCLERAL HYPERAEMIA 35 0.0514
18 CHOROIDAL EFFUSION 40 0.0498
19 CORNEAL DEGENERATION 12 0.0496
20 INTRAOCULAR PRESSURE INCREASED 626 0.0489
21 GLAUCOMA SURGERY 12 0.0469
22 FLAT ANTERIOR CHAMBER OF EYE 8 0.0447
23 CORNEA VERTICILLATA 13 0.0428
24 CORNEAL OEDEMA 91 0.0406
25 INTRAOCULAR PRESSURE TEST ABNORMAL 28 0.0397
26 ROSACEA 183 0.0392
27 PYELITIS 8 0.0385
28 INTRAOCULAR PRESSURE DECREASED 20 0.0380
29 IRIS ADHESIONS 19 0.0370
30 ANTERIOR CHAMBER DISORDER 8 0.0348
31 TREATMENT FAILURE 2879 0.0347
32 CORNEAL TRANSPLANT 26 0.0332
33 INSTILLATION SITE ERYTHEMA 17 0.0322
34 FIBROADENOMA OF BREAST 14 0.0311
35 MEIBOMIAN GLAND DYSFUNCTION 14 0.0309
36 SHORT STATURE 8 0.0305
37 GROWTH OF EYELASHES 24 0.0303
38 HYPHAEMA 15 0.0287
39 REACTION TO PRESERVATIVES 23 0.0283
40 PUNCTATE KERATITIS 25 0.0272
41 FLOPPY IRIS SYNDROME 10 0.0271
42 ANTERIOR CHAMBER INFLAMMATION 16 0.0269
43 OCULAR HYPERTENSION 51 0.0262
44 PRODUCT CLOSURE REMOVAL DIFFICULT 26 0.0255
45 GLARE 13 0.0253
46 EYE ALLERGY 37 0.0239
47 CORNEAL SCAR 12 0.0239
48 OCULAR VASCULAR DISORDER 19 0.0230
49 CONJUNCTIVITIS ALLERGIC 34 0.0229
50 CORNEAL DEPOSITS 17 0.0228
51 CONJUNCTIVAL HYPERAEMIA 79 0.0221
52 EYELID PAIN 45 0.0221
53 SUPERFICIAL INJURY OF EYE 24 0.0220
54 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 14 0.0216
55 INSTILLATION SITE PRURITUS 8 0.0212
56 KERATIC PRECIPITATES 10 0.0211
57 FOREIGN BODY SENSATION IN EYES 131 0.0205
58 CORNEAL EROSION 11 0.0204
59 GLAUCOMA 382 0.0198
60 IRIDOCYCLITIS 61 0.0193
61 PRODUCT CONTAINER ISSUE 161 0.0188
62 ENDOCRINE OPHTHALMOPATHY 16 0.0184
63 ERYTHEMA OF EYELID 98 0.0181
64 CORNEAL DISORDER 37 0.0169
65 PERIORBITAL PAIN 14 0.0165
66 PNEUMONIA HAEMOPHILUS 8 0.0165
67 OCULAR HYPERAEMIA 779 0.0164
68 EYE INFECTION BACTERIAL 9 0.0161
69 EYELID IRRITATION 39 0.0155
70 EYE LASER SURGERY 9 0.0152
71 VITRECTOMY 9 0.0151
72 CATARACT NUCLEAR 10 0.0150
73 RETINAL VASCULAR OCCLUSION 11 0.0149
74 EYE COLOUR CHANGE 15 0.0147
75 CYSTOID MACULAR OEDEMA 27 0.0143
76 BLEPHARITIS 57 0.0142
77 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 15 0.0141
78 EYE IRRITATION 812 0.0141
79 EYE PAIN 789 0.0140
80 PRODUCT DELIVERY MECHANISM ISSUE 75 0.0139
81 EYELID EXFOLIATION 11 0.0139
82 INSTILLATION SITE IRRITATION 16 0.0135
83 EYELID MARGIN CRUSTING 39 0.0135
84 EYELIDS PRURITUS 41 0.0131
85 CATARACT SUBCAPSULAR 8 0.0131
86 ANGLE CLOSURE GLAUCOMA 33 0.0129
87 OPTIC NERVE INJURY 15 0.0129
88 TOXIC ANTERIOR SEGMENT SYNDROME 14 0.0128
89 CORNEAL PERFORATION 8 0.0127
90 CONJUNCTIVAL OEDEMA 13 0.0126
91 ANTERIOR CHAMBER CELL 9 0.0126
92 REBOUND EFFECT 142 0.0126
93 FOREIGN BODY IN EYE 12 0.0125
94 EYE DISCHARGE 125 0.0120
95 VITREOUS HAEMORRHAGE 33 0.0119
96 EYE INFLAMMATION 106 0.0111
97 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 73 0.0107
98 OCULAR DISCOMFORT 120 0.0107
99 NEPHROGENIC ANAEMIA 49 0.0106
100 PRODUCT CONTAINER SEAL ISSUE 18 0.0103
101 EYE OPERATION 47 0.0102
102 VITREOUS DETACHMENT 22 0.0101
103 MACULAR OEDEMA 56 0.0100
104 HYPERPARATHYROIDISM SECONDARY 25 0.0100
105 EYE PRURITUS 334 0.0099
106 ULCERATIVE KERATITIS 27 0.0098
107 HERPES OPHTHALMIC 13 0.0098
108 ABNORMAL SENSATION IN EYE 41 0.0095
109 VITREOUS OPACITIES 8 0.0095
110 HYPERAEMIA 18 0.0091
111 EYELID DISORDER 21 0.0091
112 BLINDNESS UNILATERAL 123 0.0087
113 VISUAL FIELD DEFECT 63 0.0087
114 SKIN WARM 50 0.0086
115 IRITIS 26 0.0085
116 PRODUCT DEPOSIT 13 0.0083
117 SWELLING OF EYELID 52 0.0083
118 KERATOPATHY 13 0.0082
119 SKIN DISCOMFORT 22 0.0081
120 PRODUCT PACKAGING DIFFICULT TO OPEN 21 0.0080
121 HALO VISION 9 0.0080
122 EYE INJURY 24 0.0079
123 DACRYOSTENOSIS ACQUIRED 10 0.0077
124 VITREOUS FLOATERS 76 0.0077
125 SKIN SENSITISATION 8 0.0077
126 RETINAL DISORDER 20 0.0077
127 CONJUNCTIVITIS 142 0.0076
128 KERATITIS 23 0.0076
129 EYELID SKIN DRYNESS 9 0.0074
130 MENISCUS INJURY 45 0.0073
131 PHOTOPHOBIA 137 0.0073
132 HELICOBACTER GASTRITIS 9 0.0073
133 LACRIMATION INCREASED 216 0.0071
134 RETINAL ARTERY OCCLUSION 18 0.0071
135 METAMORPHOPSIA 13 0.0070
136 RETINAL DEGENERATION 9 0.0069
137 INSTILLATION SITE PAIN 17 0.0069
138 UVEITIS 90 0.0066
139 OPTIC NEUROPATHY 14 0.0066
140 CORNEAL ABRASION 9 0.0066
141 RETINAL DETACHMENT 58 0.0063
142 INCORRECT DOSE ADMINISTERED BY PRODUCT 10 0.0062
143 NIGHT BLINDNESS 10 0.0062
144 DRY EYE 307 0.0061
145 VISUAL ACUITY REDUCED 204 0.0061
146 EYE SWELLING 228 0.0061
147 NORMOCYTIC ANAEMIA 9 0.0061
148 OPHTHALMIC HERPES ZOSTER 11 0.0061
149 VITRITIS 11 0.0059
150 HYPERSENSITIVITY VASCULITIS 15 0.0057
151 OPTIC NERVE DISORDER 9 0.0056
152 RETINAL VEIN OCCLUSION 16 0.0056
153 WRONG PRODUCT ADMINISTERED 37 0.0055
154 SMALL INTESTINAL HAEMORRHAGE 11 0.0055
155 ASTHENOPIA 30 0.0055
156 EYE INFECTION 60 0.0053
157 ASTIGMATISM 8 0.0053
158 EYE DISORDER 173 0.0053
159 CONJUNCTIVAL HAEMORRHAGE 20 0.0052
160 BLOOD CHLORIDE INCREASED 9 0.0052
161 ELECTRIC SHOCK SENSATION 14 0.0050
162 EYELID OEDEMA 58 0.0050
163 BRONCHIAL OBSTRUCTION 7 0.0050
164 SINUS NODE DYSFUNCTION 9 0.0049
165 OPTIC ATROPHY 8 0.0049
166 PULMONARY ARTERIAL PRESSURE INCREASED 8 0.0049
167 PHOTOPSIA 31 0.0049
168 EYE OEDEMA 12 0.0049
169 ENDOPHTHALMITIS 29 0.0048
170 VISION BLURRED 656 0.0048
171 RETINAL OEDEMA 9 0.0047
172 SKIN TIGHTNESS 22 0.0047
173 PRODUCT USE COMPLAINT 71 0.0045
174 PRODUCT PACKAGE ASSOCIATED INJURY 10 0.0045
175 DIABETIC RETINOPATHY 15 0.0044
176 BLOOD LOSS ANAEMIA 10 0.0044
177 PERIARTHRITIS 10 0.0044
178 CUTANEOUS VASCULITIS 16 0.0044
179 CATARACT OPERATION 26 0.0044
180 ESSENTIAL HYPERTENSION 8 0.0044
181 VASODILATATION 11 0.0044
182 HAEMORRHAGE URINARY TRACT 11 0.0043
183 CATARACT 257 0.0043
184 SKIN INJURY 14 0.0042
185 HYPOTONIA 42 0.0042
186 MYOPIA 10 0.0042
187 DYSLIPIDAEMIA 21 0.0041
188 EYELID PTOSIS 42 0.0041
189 RETINAL TEAR 10 0.0041
190 VOCAL CORD DISORDER 8 0.0041
191 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 284 0.0040
192 REBOUND ACID HYPERSECRETION 12 0.0040
193 BLINDNESS TRANSIENT 29 0.0039
194 PERIORBITAL SWELLING 22 0.0039
195 NASAL DRYNESS 24 0.0038
196 EYE CONTUSION 8 0.0038
197 HYPERSENSITIVITY 699 0.0038
198 DERMATITIS EXFOLIATIVE GENERALISED 13 0.0037
199 END STAGE RENAL DISEASE 68 0.0037
200 ERYTHEMA 763 0.0037
201 BLINDNESS 151 0.0037
202 HORDEOLUM 16 0.0037
203 BLOOD BICARBONATE DECREASED 7 0.0037
204 EYE HAEMORRHAGE 49 0.0037
205 RETINAL HAEMORRHAGE 26 0.0036
206 CHEMICAL BURN OF SKIN 9 0.0035
207 BLOOD PRESSURE DIASTOLIC ABNORMAL 9 0.0035
208 HYPOTHERMIA 35 0.0035
209 MIOSIS 27 0.0034
210 MACULAR DEGENERATION 40 0.0033
211 VISUAL IMPAIRMENT 404 0.0033
212 BLOOD MAGNESIUM DECREASED 28 0.0032
213 BLOOD PRESSURE SYSTOLIC ABNORMAL 8 0.0032
214 DERMATITIS CONTACT 36 0.0032
215 DUODENAL ULCER HAEMORRHAGE 9 0.0031
216 HYPERKERATOSIS 17 0.0031
217 FLUSHING 312 0.0031
218 RASH MACULAR 104 0.0030
219 RETINOPATHY 11 0.0029
220 LARGE INTESTINE POLYP 20 0.0029
221 HYPOPNOEA 10 0.0029
222 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
223 PRODUCT PACKAGING ISSUE 27 0.0028
224 MACULOPATHY 10 0.0028
225 PRODUCT DISPENSING ISSUE 12 0.0028
226 FEELING HOT 171 0.0028
227 PAIN OF SKIN 74 0.0027
228 DEAFNESS NEUROSENSORY 9 0.0027
229 BENIGN PROSTATIC HYPERPLASIA 14 0.0027
230 DEPRESSED LEVEL OF CONSCIOUSNESS 107 0.0027
231 DRY MOUTH 215 0.0026
232 PALLOR 72 0.0026
233 BRADYCARDIA 140 0.0026
234 SKIN BURNING SENSATION 189 0.0026
235 BLOOD POTASSIUM ABNORMAL 7 0.0026
236 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
237 VITAMIN D DECREASED 22 0.0026
238 RESPIRATORY ACIDOSIS 10 0.0025
239 GLUCOSE TOLERANCE IMPAIRED 15 0.0025
240 PRODUCT ADMINISTRATION ERROR 50 0.0025
241 NOCTURIA 30 0.0025
242 BODY HEIGHT DECREASED 26 0.0024
243 HOSPICE CARE 24 0.0024
244 CEREBRAL HAEMATOMA 8 0.0024
245 SUPRAVENTRICULAR EXTRASYSTOLES 8 0.0024
246 DRY THROAT 24 0.0024
247 PRODUCT LABEL ISSUE 16 0.0024
248 ONYCHOMYCOSIS 10 0.0023
249 CHRONIC KIDNEY DISEASE 173 0.0023
250 NEUROLOGICAL SYMPTOM 13 0.0023
251 PRODUCT CONTAMINATION 8 0.0022
252 DERMATITIS 47 0.0022
253 PRODUCT RESIDUE PRESENT 12 0.0022
254 MYDRIASIS 28 0.0022
255 ONYCHOCLASIS 15 0.0022
256 ELECTROLYTE IMBALANCE 25 0.0021
257 FACIAL PAIN 19 0.0021
258 BLOOD PRESSURE FLUCTUATION 51 0.0021
259 PARANASAL SINUS DISCOMFORT 8 0.0021
260 LIQUID PRODUCT PHYSICAL ISSUE 15 0.0021
261 PURPURA 18 0.0020
262 HAEMOGLOBIN ABNORMAL 13 0.0020
263 EXPIRED DRUG ADMINISTERED 10 0.0020
264 RASH PAPULAR 45 0.0020
265 FLUID INTAKE REDUCED 10 0.0020
266 POOR QUALITY PRODUCT ADMINISTERED 21 0.0020
267 RECALLED PRODUCT ADMINISTERED 19 0.0020
268 DIZZINESS POSTURAL 19 0.0020
269 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
270 PERIPHERAL VASCULAR DISORDER 10 0.0019
271 IMPAIRED DRIVING ABILITY 22 0.0019
272 PHARYNGITIS 24 0.0019
273 APNOEA 15 0.0019
274 HAEMORRHAGIC STROKE 15 0.0019
275 MEDICATION ERROR 105 0.0019
276 ACCIDENTAL EXPOSURE TO PRODUCT 194 0.0019
277 SKIN SWELLING 16 0.0018
278 SCAB 21 0.0018
279 SKIN IRRITATION 84 0.0018
280 SQUAMOUS CELL CARCINOMA OF SKIN 11 0.0018
281 HYPOTHYROIDISM 58 0.0018
282 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
283 BURNING SENSATION 127 0.0018
284 DIPLOPIA 47 0.0018
285 PRODUCT USE ISSUE 340 0.0018
286 EXPIRED PRODUCT ADMINISTERED 60 0.0018
287 HYPOMAGNESAEMIA 25 0.0018
288 RASH PUSTULAR 13 0.0018
289 INTENTIONAL UNDERDOSE 13 0.0018
290 SWELLING FACE 115 0.0018
291 OPTIC NEURITIS 16 0.0018
292 EYE MOVEMENT DISORDER 12 0.0018
293 SUNBURN 13 0.0017
294 HEART RATE DECREASED 61 0.0017
295 IRON DEFICIENCY ANAEMIA 16 0.0017
296 PRODUCT STORAGE ERROR 151 0.0017
297 VASCULITIS 20 0.0017
298 NASAL CONGESTION 100 0.0017
299 SPINAL COMPRESSION FRACTURE 14 0.0017
300 DIVERTICULUM 12 0.0017
301 MYOSITIS 15 0.0017
302 LETHARGY 96 0.0017
303 MULTIPLE ALLERGIES 13 0.0017
304 ABSCESS LIMB 7 0.0016
305 APPLICATION SITE ERYTHEMA 43 0.0016
306 BLOOD PRESSURE DECREASED 109 0.0016
307 CONDITION AGGRAVATED 498 0.0016
308 ATRIAL FLUTTER 13 0.0016
309 ABNORMAL LOSS OF WEIGHT 11 0.0016
310 RHINORRHOEA 104 0.0016
311 APPLICATION SITE SWELLING 8 0.0016
312 PRODUCT LEAKAGE 9 0.0016
313 HYPOPHAGIA 41 0.0016
314 HYPERAESTHESIA 13 0.0016
315 RIB FRACTURE 32 0.0016
316 SEASONAL ALLERGY 22 0.0016
317 BLOOD UREA INCREASED 26 0.0016
318 INFLAMMATION 79 0.0015
319 PERIPHERAL COLDNESS 21 0.0015
320 RENAL TUBULAR NECROSIS 15 0.0015
321 ATRIAL FIBRILLATION 148 0.0015
322 ACTIVITIES OF DAILY LIVING IMPAIRED 30 0.0015
323 NASAL DISCOMFORT 12 0.0015
324 RENAL CYST 12 0.0015
325 BLADDER DISORDER 15 0.0015
326 DERMATITIS ALLERGIC 19 0.0015
327 CARDIAC PACEMAKER INSERTION 9 0.0015
328 DRUG INTOLERANCE 145 0.0015
329 SOMNOLENCE 301 0.0015
330 EMPHYSEMA 15 0.0015
331 SUBARACHNOID HAEMORRHAGE 15 0.0015
332 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
333 RESPIRATORY DEPRESSION 18 0.0015
334 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
335 PRODUCT PHYSICAL CONSISTENCY ISSUE 8 0.0014
336 FOOT DEFORMITY 16 0.0014
337 STREPTOCOCCAL INFECTION 8 0.0014
338 FORMICATION 10 0.0014
339 TRANSFUSION 15 0.0014
340 MASS 20 0.0014
341 EXOSTOSIS 13 0.0014
342 BALANCE DISORDER 123 0.0014
343 HEMIPARESIS 24 0.0014
344 PELVIC FRACTURE 11 0.0014
345 MENTAL STATUS CHANGES 39 0.0014
346 THERAPY NON-RESPONDER 63 0.0014
347 CARDIAC VALVE DISEASE 8 0.0014
348 SKIN DISCOLOURATION 64 0.0014
349 MIDDLE INSOMNIA 26 0.0014
350 INCOHERENT 9 0.0014
351 PSYCHOLOGICAL TRAUMA 12 0.0014
352 GLOMERULAR FILTRATION RATE DECREASED 17 0.0014
353 PRODUCT DOSE OMISSION 90 0.0014
354 AGEUSIA 34 0.0014
355 APPLICATION SITE PAIN 30 0.0014
356 RASH ERYTHEMATOUS 65 0.0014
357 APPETITE DISORDER 9 0.0014
358 HEAD DISCOMFORT 24 0.0014
359 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
360 RESPIRATORY RATE INCREASED 12 0.0014
361 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
362 TENDERNESS 14 0.0013
363 HYDRONEPHROSIS 10 0.0013
364 PHOTOSENSITIVITY REACTION 22 0.0013
365 PHARYNGEAL SWELLING 13 0.0013
366 HALLUCINATION, VISUAL 28 0.0013
367 RESPIRATORY TRACT CONGESTION 21 0.0013
368 RENAL INJURY 39 0.0013
369 HAEMATOCRIT DECREASED 26 0.0013
370 VERTIGO 79 0.0013
371 PRODUCT DISTRIBUTION ISSUE 12 0.0013
372 BLOOD POTASSIUM INCREASED 21 0.0013
373 SNEEZING 29 0.0013
374 CHOLANGITIS 8 0.0013
375 PRE-EXISTING CONDITION IMPROVED 8 0.0013
376 OESOPHAGITIS 14 0.0013
377 SKIN ULCER 33 0.0013
378 ARTERIOSCLEROSIS 12 0.0013
379 SQUAMOUS CELL CARCINOMA 12 0.0013
380 OSTEOARTHRITIS 54 0.0013
381 CELLULITIS 64 0.0013
382 ORTHOSTATIC HYPOTENSION 22 0.0013
383 ACUTE KIDNEY INJURY 193 0.0013
384 COMA 60 0.0013
385 BLOOD PRESSURE ABNORMAL 25 0.0013
386 IMMUNOSUPPRESSION 11 0.0012
387 BLOOD CALCIUM DECREASED 14 0.0012
388 RHINITIS 10 0.0012
389 FRUSTRATION TOLERANCE DECREASED 10 0.0012
390 CARDIAC FLUTTER 8 0.0012
391 EAR PAIN 24 0.0012
392 DYSPHONIA 72 0.0012
393 URINARY TRACT INFECTION 209 0.0012
394 INTERNAL HAEMORRHAGE 14 0.0012
395 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
396 FALL 407 0.0012
397 HYPOACUSIS 52 0.0012
398 PULMONARY HYPERTENSION 25 0.0012
399 SKIN LACERATION 13 0.0012
400 UROSEPSIS 11 0.0012
401 DIZZINESS 593 0.0012
402 SENSATION OF FOREIGN BODY 10 0.0012
403 INFUSION SITE ERYTHEMA 10 0.0012
404 FEELING COLD 33 0.0012
405 HYPOTENSION 237 0.0012
406 HAEMORRHOIDS 23 0.0012
407 ISCHAEMIC STROKE 21 0.0012
408 LIP SWELLING 39 0.0012
409 HYPOKINESIA 17 0.0012
410 APATHY 17 0.0012
411 OEDEMA 63 0.0012
412 RESPIRATION ABNORMAL 8 0.0012
413 JOINT EFFUSION 8 0.0012
414 SPUTUM DISCOLOURED 11 0.0012
415 BLOOD PRESSURE INCREASED 177 0.0012
416 HALLUCINATION 87 0.0012
417 RED BLOOD CELL COUNT DECREASED 33 0.0012
418 HEART RATE IRREGULAR 26 0.0011
419 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 60 0.0011
420 DEAFNESS 30 0.0011
421 EXTRASYSTOLES 8 0.0011
422 DYSPNOEA EXERTIONAL 43 0.0011
423 FULL BLOOD COUNT DECREASED 23 0.0011
424 PULMONARY MASS 17 0.0011
425 BLISTER 64 0.0011
426 PRODUCT DOSE OMISSION ISSUE 335 0.0011
427 GROIN PAIN 10 0.0011
428 SPINAL OSTEOARTHRITIS 10 0.0011
429 SINUS BRADYCARDIA 11 0.0011
430 JOINT DISLOCATION 12 0.0011
431 DUODENAL ULCER 8 0.0011
432 TINNITUS 52 0.0011
433 DISCOMFORT 69 0.0011
434 VITAMIN D DEFICIENCY 11 0.0011
435 JOINT INJURY 24 0.0011
436 ECONOMIC PROBLEM 17 0.0011
437 FLUID RETENTION 57 0.0011
438 LOCALISED INFECTION 27 0.0011
439 RENAL FAILURE 148 0.0011
440 HOT FLUSH 84 0.0011
441 SKIN EXFOLIATION 94 0.0011
442 DEMENTIA 31 0.0011
443 BACK DISORDER 18 0.0011
444 MUSCLE ATROPHY 14 0.0011
445 OSTEOMYELITIS 20 0.0011
446 UPPER LIMB FRACTURE 22 0.0011
447 PERIPHERAL SWELLING 170 0.0011
448 POST PROCEDURAL COMPLICATION 21 0.0011
449 PRODUCT QUALITY ISSUE 148 0.0011
450 BASAL CELL CARCINOMA 17 0.0011
451 BRAIN FOG 17 0.0011
452 WRIST FRACTURE 13 0.0011
453 HIATUS HERNIA 14 0.0011
454 HYPOXIA 38 0.0011
455 EAR DISCOMFORT 11 0.0011
456 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 193 0.0011
457 SCIATICA 17 0.0011
458 HAEMATEMESIS 27 0.0011
459 THERAPY INTERRUPTED 76 0.0011
460 HYPOAESTHESIA ORAL 16 0.0011
461 SINUS DISORDER 21 0.0011
462 POLLAKIURIA 44 0.0011
463 BLOOD URINE PRESENT 20 0.0011
464 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
465 INTENTIONAL PRODUCT MISUSE 92 0.0010
466 MICTURITION URGENCY 12 0.0010
467 DYSGEUSIA 78 0.0010
468 SKIN HYPERPIGMENTATION 9 0.0010
469 ADVERSE DRUG REACTION 94 0.0010
470 HYPERSOMNIA 30 0.0010
471 INSURANCE ISSUE 16 0.0010
472 BOWEL MOVEMENT IRREGULARITY 8 0.0010
473 HAEMOGLOBIN DECREASED 107 0.0010
474 PARAESTHESIA ORAL 15 0.0010
475 ATRIOVENTRICULAR BLOCK 8 0.0010
476 CONFUSIONAL STATE 167 0.0010
477 LIMB INJURY 28 0.0010
478 DELUSION 16 0.0010
479 HYPONATRAEMIA 58 0.0010
480 ORAL PAIN 23 0.0010
481 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
482 THROAT IRRITATION 46 0.0010
483 PAIN IN JAW 29 0.0010
484 DECREASED ACTIVITY 11 0.0010
485 INTENTIONAL DOSE OMISSION 29 0.0010
486 THERAPY CHANGE 10 0.0010
487 HYPERGLYCAEMIA 37 0.0010
488 ATAXIA 12 0.0010
489 SYNCOPE 101 0.0010
490 UNRESPONSIVE TO STIMULI 26 0.0010
491 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
492 GINGIVAL PAIN 8 0.0010
493 GASTROINTESTINAL HAEMORRHAGE 84 0.0010
494 GOUT 18 0.0010
495 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55 0.0010
496 COUGH 281 0.0010
497 ASTHENIA 376 0.0010
498 OROPHARYNGEAL DISCOMFORT 9 0.0010
499 SLEEP APNOEA SYNDROME 19 0.0010
500 DRUG INEFFECTIVE 1311 0.0010
501 LIP DRY 9 0.0010
502 MUSCULOSKELETAL DISCOMFORT 17 0.0010
503 SINUSITIS 101 0.0010
504 MUSCULAR WEAKNESS 112 0.0010
505 DECUBITUS ULCER 8 0.0010
506 URINARY INCONTINENCE 29 0.0010
507 NERVE COMPRESSION 9 0.0010
508 IMPAIRED QUALITY OF LIFE 14 0.0010
509 JOINT RANGE OF MOTION DECREASED 13 0.0010
510 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
511 HIP FRACTURE 31 0.0010
512 SKIN DISORDER 32 0.0010
513 HYPERTENSION 203 0.0010
514 LACERATION 9 0.0010
515 WEIGHT FLUCTUATION 10 0.0010
516 INCORRECT DOSE ADMINISTERED 218 0.0010
517 MELAENA 21 0.0010
518 PRODUCT DOSE OMISSION IN ERROR 27 0.0010
519 EPISTAXIS 71 0.0009
520 ASTHMA 107 0.0009
521 DRY SKIN 126 0.0009
522 OXYGEN SATURATION DECREASED 53 0.0009
523 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
524 HYPERKALAEMIA 33 0.0009
525 EXTRA DOSE ADMINISTERED 38 0.0009
526 ENCEPHALOPATHY 23 0.0009
527 ROTATOR CUFF SYNDROME 12 0.0009
528 WOUND 26 0.0009
529 FATIGUE 722 0.0009
530 MUSCLE STRAIN 8 0.0009
531 DYSURIA 34 0.0009
532 RENAL DISORDER 43 0.0009
533 PALPITATIONS 108 0.0009
534 PULMONARY THROMBOSIS 10 0.0009
535 THERAPEUTIC RESPONSE UNEXPECTED 41 0.0009
536 INCORRECT PRODUCT STORAGE 12 0.0009
537 ANAEMIA 174 0.0009
538 CYSTITIS 29 0.0009
539 PRURITUS 349 0.0009
540 HYPOGLYCAEMIA 44 0.0009
541 CARDIOGENIC SHOCK 13 0.0009
542 SURGERY 53 0.0009
543 CONSTIPATION 197 0.0009
544 PNEUMONIA 292 0.0009
545 NIGHT SWEATS 29 0.0009
546 HAIR TEXTURE ABNORMAL 12 0.0009
547 TREATMENT NONCOMPLIANCE 49 0.0009
548 GASTROOESOPHAGEAL REFLUX DISEASE 72 0.0009
549 NEPHROLITHIASIS 41 0.0009
550 FLUID OVERLOAD 13 0.0009
551 UPPER GASTROINTESTINAL HAEMORRHAGE 15 0.0009
552 RETCHING 19 0.0009
553 HEADACHE 558 0.0009
554 LOSS OF CONSCIOUSNESS 114 0.0009
555 ANAL INCONTINENCE 8 0.0009
556 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
557 FREQUENT BOWEL MOVEMENTS 24 0.0009
558 BLOOD CREATININE INCREASED 58 0.0009
559 SLUGGISHNESS 9 0.0009
560 PRODUCTIVE COUGH 42 0.0009
561 PRODUCT AVAILABILITY ISSUE 20 0.0009
562 SKIN HAEMORRHAGE 13 0.0009
563 INTERNATIONAL NORMALISED RATIO INCREASED 25 0.0009
564 NEUROPATHY PERIPHERAL 83 0.0009
565 OEDEMA PERIPHERAL 106 0.0009
566 DIVERTICULITIS 24 0.0009
567 DECREASED APPETITE 201 0.0009
568 EAR INFECTION 23 0.0009
569 ORAL DISCOMFORT 12 0.0009
570 MADAROSIS 10 0.0009
571 HAEMOPTYSIS 24 0.0009
572 NEPHROPATHY 8 0.0009
573 DYSSTASIA 25 0.0009
574 FLANK PAIN 8 0.0009
575 SCRATCH 9 0.0009
576 INCONTINENCE 9 0.0009
577 BLOOD SODIUM DECREASED 16 0.0008
578 CARDIAC FAILURE CONGESTIVE 68 0.0008
579 FLATULENCE 48 0.0008
580 GAIT DISTURBANCE 162 0.0008
581 HYPOCALCAEMIA 16 0.0008
582 SPINAL DISORDER 8 0.0008
583 INTENTIONAL PRODUCT USE ISSUE 74 0.0008
584 PNEUMONITIS 23 0.0008
585 BACTERAEMIA 10 0.0008
586 CONTUSION 81 0.0008
587 PNEUMONIA ASPIRATION 21 0.0008
588 DEHYDRATION 112 0.0008
589 ARTHRITIS 66 0.0008
590 SUBDURAL HAEMATOMA 12 0.0008
591 HYPERLIPIDAEMIA 10 0.0008
592 SUPRAVENTRICULAR TACHYCARDIA 8 0.0008
593 ATELECTASIS 8 0.0008
594 CYANOSIS 13 0.0008
595 PRODUCT DISPENSING ERROR 18 0.0008
596 GASTROENTERITIS 12 0.0008
597 AUTOIMMUNE DISORDER 8 0.0008
598 ORAL HERPES 16 0.0008
599 OFF LABEL USE 716 0.0008
600 DRUG EFFECT DECREASED 44 0.0008
601 ABSCESS 13 0.0008
602 CARDIOMEGALY 10 0.0008
603 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 39 0.0008
604 TACHYPNOEA 11 0.0008
605 CARDIAC MURMUR 7 0.0008
606 GAIT INABILITY 27 0.0008
607 UNEVALUABLE EVENT 61 0.0008
608 CYST 10 0.0008
609 BACTERIAL INFECTION 15 0.0008
610 ARRHYTHMIA 38 0.0008
611 RESPIRATORY DISORDER 24 0.0008
612 CORONARY ARTERY OCCLUSION 11 0.0008
613 PRODUCT SUBSTITUTION ISSUE 46 0.0008
614 BLOOD POTASSIUM DECREASED 24 0.0008
615 HAEMATOCHEZIA 44 0.0008
616 DYSARTHRIA 30 0.0008
617 IMPAIRED HEALING 26 0.0008
618 CHEST DISCOMFORT 81 0.0008
619 DYSPNOEA 447 0.0008
620 TASTE DISORDER 16 0.0008
621 PRURITUS GENERALISED 17 0.0008
622 BLOOD TEST ABNORMAL 11 0.0008
623 PULMONARY OEDEMA 35 0.0008
624 NEURALGIA 19 0.0008
625 PRODUCT PRESCRIBING ISSUE 17 0.0008
626 NIGHTMARE 27 0.0008
627 SWELLING 73 0.0008
628 URINARY RETENTION 26 0.0008
629 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
630 LYMPHOPENIA 11 0.0008
631 LIMB DISCOMFORT 24 0.0008
632 PARAESTHESIA 122 0.0008
633 TOOTHACHE 14 0.0008
634 HAEMATOMA 20 0.0008
635 VENTRICULAR EXTRASYSTOLES 8 0.0008
636 SKIN FISSURES 15 0.0008
637 PLATELET COUNT INCREASED 10 0.0008
638 NODULE 10 0.0008
639 SLEEP DISORDER 54 0.0008
640 PAIN IN EXTREMITY 225 0.0008
641 WEIGHT DECREASED 213 0.0008
642 INFLUENZA 85 0.0008
643 RESPIRATORY DISTRESS 21 0.0008
644 GASTRITIS 20 0.0008
645 ANOSMIA 11 0.0008
646 HAEMATURIA 26 0.0008
647 TOOTH INFECTION 10 0.0008
648 BLOOD IRON DECREASED 9 0.0008
649 HEAD INJURY 24 0.0008
650 RENAL PAIN 8 0.0008
651 EPILEPSY 23 0.0008
652 PRESCRIBED UNDERDOSE 15 0.0008
653 ACNE 57 0.0008
654 POLYNEUROPATHY 9 0.0008
655 DIARRHOEA 485 0.0008
656 BLOOD CHOLESTEROL INCREASED 35 0.0008
657 METABOLIC ACIDOSIS 24 0.0007
658 FUNGAL INFECTION 25 0.0007
659 SENSORY DISTURBANCE 12 0.0007
660 RECTAL HAEMORRHAGE 32 0.0007
661 DEVICE USE ISSUE 13 0.0007
662 BRONCHITIS 55 0.0007
663 DYSPEPSIA 73 0.0007
664 RASH 323 0.0007
665 DEPRESSED MOOD 39 0.0007
666 SWOLLEN TONGUE 23 0.0007
667 PROTEINURIA 14 0.0007
668 HAEMORRHAGE INTRACRANIAL 11 0.0007
669 MEMORY IMPAIRMENT 101 0.0007
670 BACK PAIN 170 0.0007
671 SMALL INTESTINAL OBSTRUCTION 9 0.0007
672 RENAL FAILURE ACUTE 31 0.0007
673 WOUND INFECTION 8 0.0007
674 NERVOUSNESS 38 0.0007
675 GENERALISED OEDEMA 9 0.0007
676 HEART RATE INCREASED 72 0.0007
677 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
678 THERAPEUTIC RESPONSE DECREASED 44 0.0007
679 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 147 0.0007
680 HERNIA 14 0.0007
681 DRUG DOSE OMISSION 119 0.0007
682 RASH PRURITIC 39 0.0007
683 TOOTH DISORDER 16 0.0007
684 HYPERTENSIVE CRISIS 8 0.0007
685 SECRETION DISCHARGE 9 0.0007
686 APHONIA 10 0.0007
687 NECK PAIN 40 0.0007
688 HERPES ZOSTER 41 0.0007
689 NEPHROPATHY TOXIC 8 0.0007
690 KNEE ARTHROPLASTY 15 0.0007
691 ACUTE MYOCARDIAL INFARCTION 21 0.0007
692 MOUTH ULCERATION 15 0.0007
693 MUSCULOSKELETAL CHEST PAIN 11 0.0007
694 ANKLE FRACTURE 11 0.0007
695 PRODUCT COMPLAINT 18 0.0007
696 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13 0.0007
697 HEPATOCELLULAR INJURY 10 0.0007
698 THROAT TIGHTNESS 19 0.0007
699 OROPHARYNGEAL PAIN 65 0.0007
700 INSOMNIA 187 0.0007
701 BRAIN INJURY 7 0.0007
702 POOR QUALITY SLEEP 15 0.0007
703 DIABETES MELLITUS 53 0.0007
704 HYPOAESTHESIA 104 0.0007
705 LUNG DISORDER 34 0.0007
706 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
707 WHEEZING 41 0.0007
708 DRUG EFFECT INCOMPLETE 25 0.0007
709 BLOOD GLUCOSE DECREASED 33 0.0007
710 FRACTURE 13 0.0007
711 DYSPHAGIA 65 0.0007
712 FEELING JITTERY 13 0.0007
713 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
714 ACUTE RESPIRATORY FAILURE 13 0.0007
715 GALLBLADDER DISORDER 12 0.0007
716 MALIGNANT MELANOMA 9 0.0007
717 PRODUCT PRESCRIBING ERROR 16 0.0007
718 RHEUMATOID ARTHRITIS 76 0.0007
719 TREMOR 111 0.0007
720 ABDOMINAL DISCOMFORT 112 0.0007
721 GASTROENTERITIS VIRAL 12 0.0007
722 ERECTILE DYSFUNCTION 17 0.0007
723 ABDOMINAL PAIN 154 0.0007
724 CORONARY ARTERY DISEASE 20 0.0007
725 ADRENAL INSUFFICIENCY 8 0.0007
726 GINGIVAL BLEEDING 9 0.0007
727 RESPIRATORY FAILURE 48 0.0007
728 RENAL IMPAIRMENT 55 0.0007
729 DRUG DISPENSING ERROR 10 0.0007
730 SPINAL OPERATION 8 0.0006
731 MUSCULOSKELETAL PAIN 34 0.0006
732 PERICARDIAL EFFUSION 15 0.0006
733 BONE PAIN 38 0.0006
734 CHILLS 76 0.0006
735 THROMBOSIS 52 0.0006
736 FAECES DISCOLOURED 14 0.0006
737 AMNESIA 42 0.0006
738 PRODUCT PHYSICAL ISSUE 13 0.0006
739 BIPOLAR DISORDER 7 0.0006
740 ABDOMINAL PAIN UPPER 132 0.0006
741 MALAISE 281 0.0006
742 HEPATIC CIRRHOSIS 12 0.0006
743 CEREBROVASCULAR ACCIDENT 108 0.0006
744 STAPHYLOCOCCAL INFECTION 21 0.0006
745 DEVICE DEFECTIVE 11 0.0006
746 DEPRESSION 144 0.0006
747 OSTEOPOROSIS 26 0.0006
748 CHEST PAIN 117 0.0006
749 DEEP VEIN THROMBOSIS 41 0.0006
750 CARDIAC DISORDER 59 0.0006
751 ARTHROPATHY 35 0.0006
752 ACCIDENTAL OVERDOSE 23 0.0006
753 ULCER 10 0.0006
754 ALOPECIA 123 0.0006
755 COLD SWEAT 11 0.0006
756 ROAD TRAFFIC ACCIDENT 26 0.0006
757 JOINT SWELLING 75 0.0006
758 COVID-19 109 0.0006
759 NASOPHARYNGITIS 114 0.0006
760 EXPOSURE VIA SKIN CONTACT 16 0.0006
761 PRESYNCOPE 15 0.0006
762 PLASMA CELL MYELOMA 24 0.0006
763 RESPIRATORY TRACT INFECTION 16 0.0006
764 FEELING ABNORMAL 147 0.0006
765 GASTRIC DISORDER 21 0.0006
766 ELECTROCARDIOGRAM QT PROLONGED 22 0.0006
767 SPEECH DISORDER 32 0.0006
768 BLOOD GLUCOSE INCREASED 115 0.0006
769 LABORATORY TEST ABNORMAL 18 0.0006
770 CARDIOMYOPATHY 9 0.0006
771 PLEURAL EFFUSION 37 0.0006
772 ADVERSE EVENT 56 0.0006
773 DISABILITY 12 0.0006
774 HYPOKALAEMIA 28 0.0006
775 UNDERDOSE 44 0.0006
776 PRODUCT USE IN UNAPPROVED INDICATION 149 0.0006
777 RESTLESSNESS 22 0.0006
778 SPINAL FRACTURE 12 0.0006
779 ARTHRALGIA 249 0.0006
780 CARDIAC FAILURE 48 0.0006
781 GLYCOSYLATED HAEMOGLOBIN INCREASED 15 0.0006
782 STOMATITIS 36 0.0006
783 OSTEOPENIA 9 0.0006
784 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 20 0.0006
785 SINUS CONGESTION 8 0.0006
786 SEPSIS 66 0.0006
787 MOVEMENT DISORDER 19 0.0006
788 NO ADVERSE EVENT 107 0.0006
789 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 42 0.0006
790 INFECTION 85 0.0006
791 DRUG ADMINISTRATION ERROR 18 0.0006
792 WEIGHT INCREASED 131 0.0006
793 THYROID DISORDER 9 0.0006
794 MUSCLE SPASMS 107 0.0006
795 GLOSSODYNIA 13 0.0006
796 RASH GENERALISED 15 0.0006
797 GASTRIC ULCER 11 0.0006
798 BURSITIS 7 0.0006
799 THERAPY PARTIAL RESPONDER 9 0.0006
800 PAIN 354 0.0006
801 COORDINATION ABNORMAL 8 0.0006
802 LOCAL SWELLING 10 0.0006
803 APPLICATION SITE PRURITUS 13 0.0006
804 ERUCTATION 11 0.0006
805 DEVICE OCCLUSION 8 0.0006
806 ABASIA 14 0.0006
807 DISEASE PROGRESSION 67 0.0006
808 DYSKINESIA 23 0.0006
809 LYMPHOCYTE COUNT DECREASED 10 0.0006
810 EATING DISORDER 12 0.0006
811 APHASIA 17 0.0006
812 BRONCHOSPASM 8 0.0006
813 DISORIENTATION 22 0.0006
814 DRUG INTERACTION 88 0.0006
815 COLITIS 21 0.0006
816 GENERAL PHYSICAL HEALTH DETERIORATION 64 0.0006
817 RESTLESS LEGS SYNDROME 10 0.0005
818 FEMUR FRACTURE 17 0.0005
819 IRRITABILITY 33 0.0005
820 BONE DISORDER 10 0.0005
821 WHITE BLOOD CELL COUNT INCREASED 21 0.0005
822 MYALGIA 93 0.0005
823 ASPARTATE AMINOTRANSFERASE INCREASED 29 0.0005
824 THROMBOCYTOPENIA 61 0.0005
825 EMOTIONAL DISTRESS 66 0.0005
826 NAUSEA 431 0.0005
827 PLATELET COUNT DECREASED 58 0.0005
828 PYREXIA 187 0.0005
829 COAGULOPATHY 9 0.0005
830 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
831 RASH MACULO-PAPULAR 12 0.0005
832 BODY TEMPERATURE INCREASED 11 0.0005
833 COLON CANCER 8 0.0005
834 PANCYTOPENIA 30 0.0005
835 MENTAL IMPAIRMENT 13 0.0005
836 GASTROINTESTINAL DISORDER 48 0.0005
837 TACHYCARDIA 47 0.0005
838 SEPTIC SHOCK 23 0.0005
839 ABDOMINAL DISTENSION 55 0.0005
840 WHITE BLOOD CELL COUNT DECREASED 57 0.0005
841 DEVICE FAILURE 8 0.0005
842 MUSCULOSKELETAL DISORDER 10 0.0005
843 MIGRAINE 50 0.0005
844 ANGINA PECTORIS 15 0.0005
845 MUSCLE TWITCHING 12 0.0005
846 DRUG PRESCRIBING ERROR 10 0.0005
847 HYPERHIDROSIS 67 0.0005
848 ECZEMA 27 0.0005
849 THERAPEUTIC PRODUCT EFFECT DECREASED 23 0.0005
850 CHOKING 10 0.0005
851 SKIN CANCER 11 0.0005
852 BONE DENSITY DECREASED 16 0.0005
853 KIDNEY INFECTION 10 0.0005
854 ANXIETY 145 0.0005
855 HAEMORRHAGE 53 0.0005
856 THERAPY CESSATION 26 0.0005
857 PNEUMOTHORAX 8 0.0005
858 HOSPITALISATION 77 0.0005
859 MOBILITY DECREASED 36 0.0005
860 CYTOKINE RELEASE SYNDROME 10 0.0005
861 DEATH 429 0.0005
862 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
863 LACTIC ACIDOSIS 16 0.0005
864 TOXICITY TO VARIOUS AGENTS 83 0.0005
865 AGITATION 36 0.0005
866 VOMITING 230 0.0005
867 CARDIAC ARREST 40 0.0005
868 FEAR 13 0.0005
869 JAUNDICE 13 0.0005
870 URTICARIA 80 0.0005
871 CEREBRAL HAEMORRHAGE 17 0.0005
872 CANDIDA INFECTION 8 0.0005
873 PULMONARY EMBOLISM 45 0.0005
874 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 8 0.0005
875 ABNORMAL DREAMS 13 0.0005
876 CHOLESTASIS 9 0.0005
877 IMPAIRED WORK ABILITY 10 0.0005
878 SCAR 8 0.0005
879 NEUTROPHIL COUNT DECREASED 19 0.0005
880 BONE LOSS 7 0.0005
881 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
882 SEIZURE 53 0.0005
883 CHOLELITHIASIS 15 0.0005
884 ANHEDONIA 12 0.0005
885 MUSCULOSKELETAL STIFFNESS 40 0.0005
886 PANCREATITIS 24 0.0005
887 FIBROMYALGIA 11 0.0005
888 STEVENS-JOHNSON SYNDROME 10 0.0004
889 FEEDING DISORDER 9 0.0004
890 MYOCARDIAL INFARCTION 77 0.0004
891 MOOD ALTERED 12 0.0004
892 MENTAL DISORDER 19 0.0004
893 PROCEDURAL PAIN 12 0.0004
894 THINKING ABNORMAL 8 0.0004
895 ILLNESS 44 0.0004
896 INCORRECT DRUG ADMINISTRATION DURATION 12 0.0004
897 FOOT FRACTURE 8 0.0004
898 LOWER LIMB FRACTURE 8 0.0004
899 DIABETIC KETOACIDOSIS 10 0.0004
900 ANAPHYLACTIC REACTION 23 0.0004
901 TYPE 2 DIABETES MELLITUS 14 0.0004
902 LIVER FUNCTION TEST ABNORMAL 12 0.0004
903 HEPATIC ENZYME INCREASED 28 0.0004
904 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
905 CHROMATURIA 9 0.0004
906 LYMPHADENOPATHY 14 0.0004
907 INJURY ASSOCIATED WITH DEVICE 8 0.0004
908 SHOCK 9 0.0004
909 DEVICE ISSUE 35 0.0004
910 PRODUCT PREPARATION ERROR 8 0.0004
911 LUNG NEOPLASM MALIGNANT 16 0.0004
912 EMOTIONAL DISORDER 12 0.0004
913 INFLUENZA LIKE ILLNESS 32 0.0004
914 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
915 CRYING 14 0.0004
916 C-REACTIVE PROTEIN INCREASED 14 0.0004
917 ANGER 13 0.0004
918 JOINT STIFFNESS 10 0.0004
919 INTERSTITIAL LUNG DISEASE 18 0.0004
920 INTESTINAL OBSTRUCTION 14 0.0004
921 DISTURBANCE IN ATTENTION 20 0.0004
922 DEVICE DELIVERY SYSTEM ISSUE 10 0.0004
923 SKIN LESION 10 0.0004
924 INJECTION SITE HAEMORRHAGE 29 0.0004
925 RESPIRATORY ARREST 10 0.0004
926 THERAPEUTIC RESPONSE SHORTENED 12 0.0004
927 NEUTROPENIA 49 0.0004
928 MULTIPLE SCLEROSIS 17 0.0004
929 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
930 INFUSION RELATED REACTION 23 0.0003
931 PSORIATIC ARTHROPATHY 14 0.0003
932 PSORIASIS 45 0.0003
933 NEEDLE ISSUE 10 0.0003
934 COGNITIVE DISORDER 16 0.0003
935 CARDIO-RESPIRATORY ARREST 14 0.0003
936 PANIC ATTACK 12 0.0003
937 OSTEONECROSIS OF JAW 8 0.0003
938 DERMATITIS ATOPIC 17 0.0003
939 NERVOUS SYSTEM DISORDER 10 0.0003
940 NEOPLASM PROGRESSION 11 0.0003
941 MOOD SWINGS 10 0.0003
942 INCORRECT ROUTE OF DRUG ADMINISTRATION 11 0.0003
943 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
944 FEBRILE NEUTROPENIA 20 0.0003
945 VIRAL INFECTION 10 0.0003
946 INJECTION SITE PRURITUS 20 0.0003
947 ILL-DEFINED DISORDER 18 0.0003
948 DISEASE RECURRENCE 14 0.0003
949 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
950 LIVER DISORDER 13 0.0003
951 DEVICE DIFFICULT TO USE 19 0.0003
952 CEREBRAL INFARCTION 7 0.0003
953 NEOPLASM MALIGNANT 19 0.0003
954 INJURY 20 0.0003
955 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 13 0.0003
956 ABDOMINAL PAIN LOWER 7 0.0003
957 ASCITES 8 0.0003
958 ANAPHYLACTIC SHOCK 7 0.0003
959 INJECTION SITE PAIN 83 0.0003
960 OVERDOSE 57 0.0003
961 AGGRESSION 13 0.0003
962 DELIRIUM 9 0.0003
963 GYNAECOMASTIA 8 0.0003
964 VAGINAL HAEMORRHAGE 11 0.0003
965 DEVICE DISLOCATION 11 0.0003
966 ABNORMAL BEHAVIOUR 10 0.0003
967 SUICIDAL IDEATION 23 0.0003
968 INJECTION SITE MASS 9 0.0002
969 HEPATIC FUNCTION ABNORMAL 9 0.0002
970 LEUKOPENIA 12 0.0002
971 INJECTION SITE BRUISING 18 0.0002
972 INJECTION SITE SWELLING 17 0.0002
973 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
974 DEVICE MALFUNCTION 15 0.0002
975 CONVULSION 12 0.0002
976 ANGIOEDEMA 9 0.0002
977 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
978 DEVICE BREAKAGE 8 0.0002
979 RHABDOMYOLYSIS 8 0.0002
980 WITHDRAWAL SYNDROME 8 0.0002
981 INJECTION SITE REACTION 13 0.0002
982 PROSTATE CANCER 15 0.0002
983 INJECTION SITE ERYTHEMA 21 0.0002
984 BREAST CANCER 14 0.0002
985 INTENTIONAL OVERDOSE 8 0.0001
986 BLADDER CANCER 7 0.0001
987 DRUG WITHDRAWAL SYNDROME 10 0.0001
988 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
989 DRUG DEPENDENCE 10 0.0001